Research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet needs.

Sectors
Healthcare
Life Sciences
First Invested
2011
Public/PIPES
Company Status
IPO/Public
NASDAQ: NKTR
Associated Team
Paul Walker